Ex-Intel head says TSMC’s new investment will not resurrect US chip sector In 2024, Fosun International achieved total revenue of RMB192.14 billion, with industrial operation profit, a key indicator ...

In the past year, we sustained steady growth momentum and demonstrated robust resilience in the face of global economic fluctuations and market challenges. We continuously advanced our core ...

Total revenue reached RMB192.14 billion; Industrial operation profit amounted to RMB4.9 billion; Total revenue generated by the four core subsidiar ...

In November 2024, after an absence of three years, Fosun returned to the ... High-quality global operations have become a new growth engine for Fosun. In 2024, Fosun Insurance Portugal maintained ...

Fosun has maintained long-term, close partnerships with leading banks worldwide while continuously expanding its financing channels. Recently, the Company signed strategic cooperation agreements with ...

Co., Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...

Fosun International Limited (HKEX stock code: 00656) announced its annual results for the year 2024. During the period, the Group's total revenue reached RMB192.14 billion. Its four core subsidiaries ...

In November of last year, Fosun bought back the shares from PEAK6 for a sum of around £39million, a development that hinted ...

Fosun International (OTCPK:FOSUF) refinanced a $870M syndicated loan due on March 28, 2025. Of this amount, $675M equivalent was secured through a newly arranged syndicated loan. Consistent with the ...

Ltd. ("Fosun Pharma"or "the Group"; Stock Code: 600196.SH, 02196.HK), a leading global pharmaceutical and healthcare company driven by innovation, announced its annual results for the year ended ...